BenevolentAI is a British technology company harnessing the power of AI to enhance and accelerate scientific discovery by turning the world’s highly fragmented scientific research data into new insight and usable knowledge that benefits society.
Jérôme is a world leading pioneer in AI and has been focused on big data and machine learning for the past 16 years. He joins BenevolentAI from IBM Watson where he created and led the development of the Watson Platform. At IBM Jérôme also held the role of Chief Scientist for the core IBM Big Data product portfolio. Prior to joining IBM, Jérôme co-founded search and text analytics company Vivisimo that was acquired by IBM in 2012. At Benevolet AI, one of Jérôme’s key roles will be to develop and drive the wider applications of BenevolentAI’s technology outside of human healthcare and drug discovery.
Ken Mulvany, Chairman of BenevolentAI commented: “Given Jérôme’s incredible experience in the AI and deep learning space, we’re delighted to have him on board. As a company we are making exciting progress in human healthcare and drug discovery but our ambition is to use our technology to accelerate all scientific discovery and apply AI to solve some of the world’s biggest problems. Jérôme’s appointment signals a huge leap forward, not only for our technology team, but for our overall vision.”